Results 101 to 110 of about 18,339,616 (353)
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Nonalcoholic steatohepatitis (NASH) is becoming common chronic liver disease because of the increasing global prevalence of obesity and consequently Nonalcoholic fatty liver disease (NAFLD).
Ji-Young Cha +2 more
semanticscholar +1 more source
ABSTRACT Objective Sleep disturbances have been implicated as a risk factor for developing Alzheimer's disease (AD), but evidence linking plasma AD biomarkers to sleep in cognitively unimpaired individuals remains limited. The present study examined associations between evening, morning, and overnight changes in plasma AD biomarkers and measures of ...
Cornelia Sauter +5 more
wiley +1 more source
The impact of liver disease on cognitive functioning and mood. [PDF]
The following review discusses some of the cognitive and functional problems in liver disease. Some medical literature is included which is consistent with difficulties reported by patients.
Perkins, K.
core
White Matter Hyperintensities Modify CYP2C19 Effect on Stroke Progression in Small Vessel Occlusion
ABSTRACT Background The association between CYP2C19 loss‐of‐function (LOF) alleles and early neurological deterioration (END) in acute small vessel occlusion (SVO) patients receiving dual antiplatelet therapy (DAPT) remains inconsistent. We hypothesized that white matter hyperintensities (WMH) burden act as a key moderator and investigated whether this
Xiaoxin Sun +5 more
wiley +1 more source
Alpha‐1‐anti‐trypsin deficiency is the most common genetic cause of liver disease in children and liver transplantation is currently the only available treatment.
N. Pastore +14 more
semanticscholar +1 more source
Objective Race and household income impact outcomes in patients with rheumatic conditions; however, their role in pediatric antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) remains poorly understood. We aimed to evaluate whether race and ethnicity and household income are associated with severe AAV disease and renal outcomes among
Roberto Alejandro Valdovinos +2 more
wiley +1 more source
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are rapidly reshaping care for metabolic and cardiovascular disease, with roles now extending from type 2 diabetes to obesity, cardiovascular protection, fatty liver disease, and possible ...
Hariny Muthuraj +3 more
doaj +1 more source
Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease.
Hamamoto Filho, Pedro Tadao [UNESP] +13 more
core +1 more source
Kunlei Zhu,* Tong Zhu,* Changyou Jing, Yonghong Zhang, Jianjun Li Hepatic Disease and Oncology Minimally Invasive Interventional Center, Beijing YouAn Hospital, Capital Medical University, Beijing, People’s Republic of China*These
Zhu K, Zhu T, Jing C, Zhang Y, Li J
doaj
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato +27 more
wiley +1 more source

